ストックスクリーナーアプリを入手
12.99
0.46%
-0.0961
前日終値:
$13.09
開ける：
$13.13
24時間の取引高:
292.43K
Relative Volume:
0.28
時価総額：
$896.06M
収益：
$46.02M
当期純損益:
$-70.80M
株価収益率:
-7.1395
EPS:
-1.82
ネットキャッシュフロー:
$-1.61M
1週間 パフォーマンス:
+7.60%
1か月 パフォーマンス:
-5.10%
6か月 パフォーマンス:
+78.49%
1年 パフォーマンス:
+8.04%
1日の値動き範囲:
$12.96
$13.34
1週間の範囲:
$11.55
$13.34
52週間の値動き範囲:
$3.91
$14.91
Eyepoint Pharmaceuticals Inc Stock (EYPT) Company Profile
名前
Eyepoint Pharmaceuticals Inc
セクター
電話
617-926-5000
住所
480 PLEASANT STREET, WATERTOWN, MA
EYPT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EYPT
Eyepoint Pharmaceuticals Inc
|
13.00 | 1.06B | 46.02M | -70.80M | -1.61M | -1.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.25 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.23 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.03 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
829.86 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.66 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-17 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-07 | 開始されました | Citigroup | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-08-28 | 開始されました | Jefferies | Buy |
| 2024-01-22 | 開始されました | JP Morgan | Overweight |
| 2023-11-02 | 開始されました | Mizuho | Buy |
| 2023-04-21 | 開始されました | Robert W. Baird | Outperform |
| 2022-07-07 | 開始されました | Chardan Capital Markets | Buy |
| 2021-03-01 | 開始されました | Cowen | Outperform |
| 2021-01-28 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-04-06 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2019-11-04 | 再開されました | Laidlaw | Buy |
| 2019-09-12 | 開始されました | Guggenheim | Buy |
すべてを表示
Eyepoint Pharmaceuticals Inc (EYPT) 最新ニュース
How EyePoint Pharmaceuticals Inc. stock performs in high volatility marketsWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com
EyePoint Announces Participation at Upcoming Investor Conferences - EyePoint Pharmaceuticals
EyePoint (NASDAQ: EYPT) to appear at Guggenheim, Stifel and Jefferies investor events - Stock Titan
Should you wait for a breakout in EyePoint Pharmaceuticals Inc.Market Sentiment Summary & Daily Profit Focused Screening - newser.com
Is EyePoint Pharmaceuticals Inc. stock ready for breakoutQuarterly Risk Review & Weekly Stock Breakout Alerts - newser.com
What’s next for EyePoint Pharmaceuticals Inc. stock priceTrade Volume Summary & Fast Entry High Yield Tips - newser.com
EyePoint Pharmaceuticals Inc. stock outlook for YEAROptions Play & Precise Trade Entry Recommendations - newser.com
Will EyePoint Pharmaceuticals Inc. (PV3B) stock deliver compounding returnsPortfolio Performance Summary & Long-Term Capital Growth Ideas - newser.com
Has EyePoint Pharmaceuticals Inc. formed a bullish divergenceJobs Report & Growth Oriented Trading Recommendations - newser.com
Will EyePoint Pharmaceuticals Inc. stock split attract more investorsBond Market & AI Powered Market Trend Analysis - newser.com
Is EyePoint Pharmaceuticals Inc. (PV3B) stock a buy before new product rollout - newser.com
Combining price and volume data for EyePoint Pharmaceuticals Inc.July 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
EyePoint Pharmaceuticals (NASDAQ:EYPT) shareholder returns have been stellar, earning 212% in 5 years - simplywall.st
Eyepoint Pharmaceuticals (EYPT) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
EyePoint Pharmaceuticals Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Consistently Superior Profits - earlytimes.in
With 57% institutional ownership, EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) is a favorite amongst the big guns - Yahoo Finance
Will EyePoint Pharmaceuticals Inc. stock outperform growth indexesTrade Risk Report & Free High Return Stock Watch Alerts - newser.com
EyePoint Pharmaceuticals to Host Conference Call for Q3 2025 Financial Results on November 5, 2025 - Quiver Quantitative
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times
EyePoint Pharmaceuticals (NASDAQ: EYPT) sets 8:30 a.m. ET call to discuss Q3 results - Stock Titan
Will EyePoint Pharmaceuticals Inc. stock see insider buyingJuly 2025 Momentum & Weekly High Momentum Picks - fcp.pa.gov.br
Is EyePoint Pharmaceuticals Inc. stock recession proof2025 Risk Factors & Verified Short-Term Trading Plans - fcp.pa.gov.br
Is EyePoint Pharmaceuticals Inc. stock a safe buy before earningsWeekly Stock Recap & Smart Money Movement Tracker - fcp.pa.gov.br
EyePoint Pharmaceuticals Completes US$150 Million Follow-On Equity Offering - Global Legal Chronicle
What drives EyePoint Pharmaceuticals Inc stock priceDouble Top/Bottom Patterns & Maximize Gains Professionally - earlytimes.in
Eyepoint Pharmaceuticals Inc (EYPT) 財務データ
収益
当期純利益
現金流量
EPS
0.21%
0.96%
大文字化:
|
ボリューム (24 時間):